Development of a patient-reported outcome measure for children with streptococcal pharyngitis

Pediatrics

Volumn 124, Issue 4, 2009, Pages

  Shaikh, Nader ^a,e   Martin, Judith M ^a   Casey, Janet R ^b   Pichichero, Michael E ^b   Wald, Ellen R ^c   Colborn, D Kathleen ^a   Gerber, Michael A ^d   Kearney, Diana H ^a   Balentine, Tracy L ^a   Haralam, Mary Ann ^a   Hoberman, Alejandro ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Rochester General Research Institute   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Patient reported outcome; Pediatrics; Streptococcal pharyngitis; Symptoms

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SCHOOL CHILD; SCORING SYSTEM; STREPTOCOCCAL PHARYNGITIS; STREPTOCOCCUS GROUP A;

ADOLESCENT; AGE FACTORS; ANTI-BACTERIAL AGENTS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICAL RECORDS; OBSERVER VARIATION; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; PATIENT PARTICIPATION; PHARYNGITIS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 70349728532     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-0331     Document Type: Article

References (20)

1. Powers JH. Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials. Pharmacotherapy. 2005;25(12 pt 2):109S-123S
2. Guidance for industry: patient-reported outcome measures - use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79
3. Varni JW, Limbers CA, Burwinkle TM. How young can children reliably and validly self-report their health-related quality of life? An analysis of 8,591 children across age subgroups with the PedsQL 4.0 Generic Core Scales. Health Qual Life Outcomes. 2007;5:1
4. Bennike T, Brochner-Mortensen K, Kjaer E, Skadhauge K, Trolle E. Penicillin therapy in acute tonsillitis, phlegmonous tonsillitis and ulcerative tonsillitis. Acta Med Scand. 1951;139(4):253-274
5. el-Daher NT, Hijazi SS, Rawashdeh NM, al-Khalil IA, Abu-Ektaish FM, Abdel-Latif DI. Immediate vs. delayed treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin V. Pediatr Infect Dis J. 1991;10(2):126-130
6. Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis: placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA. 1985;253(9):1271-1274
7. Nelson JD. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis. Pediatr Infect Dis. 1984;3(1):10-13
8. Pichichero ME, Disney FA, Talpey WB, et al. Adverse and beneficial effects of immediate treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin. Pediatr Infect Dis J. 1987;6(7): 635-643 (Pubitemid 17098161)
9. Randolph MF, Gerber MA, DeMeo KK, Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr. 1985;106(6):870-875 (Pubitemid 15006627)
10. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21(1):77-83
11. Shaikh N, Hoberman A, Paradise JL, et al. Responsiveness and construct validity of a symptom scale for acute otitis media. Pediatr Infect Dis J. 2009;28(1):9-12
12. Shaikh N, Hoberman A, Paradise JL, et al. Development and preliminary evaluation of a parentreported outcome instrument for clinical trials in acute otitis media. Pediatr Infect Dis J. 2009; 28(1):5-8
13. Bieri D, Reeve RA, Champion GD, Addicoat L, Ziegler JB. The Faces pain scale for the selfassessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain. 1990;41(2):139-150 (Pubitemid 20179927)
14. Stein RE, Jessop DJ. Functional Status II(R): a measure of child health status. Med Care. 1990; 28(11):1041-1055
15. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis. 1987;40(2):171-178 (Pubitemid 17007065)
16. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials. 1991;12(4 suppl):142S-158S
17. Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. CMAJ. 1986;134(8):889-895 (Pubitemid 16013788)
18. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a diseasespecific Quality of Life Questionnaire. J Clin Epidemiol. 1994;47(1):81-87 (Pubitemid 24034293)
19. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407-415 (Pubitemid 20025670)
20. Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes. 2006;4:70 (Pubitemid 44649667)